
|Videos|July 23, 2014
Post-Therapy Imaging in Lymphoma
Author(s)Kenneth R. Carson, MD
Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses post-therapy imaging in lymphoma.
Advertisement
Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses post-therapy imaging in lymphoma.
Clinical Pearls:
- Those in favor of post-therapy imaging would say patients may receive clinical benefit from surveillance imaging.
- There is no evidence that suggests that post-therapy imaging improves overall survival.
- Post-therapy imaging is also expensive and radiation exposure may harm the patient.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
3
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
4
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
5








































